Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Rational optimization of a transcription factor activation domain inhibitor

  • Basu, Shaon|||0000-0003-2648-4827
  • Martínez-Cristóbal, Paula|||0000-0002-8464-3884
  • Frigolé-Vivas, Marta
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Lewis, Michael
  • Szulc, Elzbieta
  • Bañuelos, C. Adriana
  • Sánchez-Zarzalejo, Carolina|||0000-0002-7059-5658
  • Bielskutė, Stasė
  • Zhu, Jiaqi
  • Pombo-García, Karina|||0000-0002-2077-5909
  • Garcia-Cabau, Carla|||0000-0003-0533-0642
  • Zodi, Levente
  • Dockx, Hannes
  • Smak, Jordann
  • Kaur, Harpreet|||0000-0003-0421-8341
  • Batlle Carreras, Cristina|||0000-0003-4903-831X
  • Mateos, Borja|||0000-0002-0310-4943
  • Biesaga, Mateusz|||0000-0001-6443-1270
  • Escobedo, Albert|||0000-0001-7295-5111
  • Bardia, Lídia
  • Verdaguer, Xavier|||0000-0002-9229-969X
  • Ruffoni, Alessandro|||0000-0001-8617-2548
  • Mawji, Nasrin R.
  • Wang, Jun
  • Obst, Jon K.
  • Tam, Teresa
  • Brun-Heath, Isabelle|||0000-0002-5828-0020
  • Ventura, Salvador|||0000-0002-9652-6351
  • Meierhofer, David|||0000-0002-0170-868X
  • García, Jesús|||0000-0003-2961-9790
  • Robustelli, Paul|||0000-0002-9282-8993
  • Stracker, Travis H.|||0000-0002-8650-2081
  • Sadar, Marianne D.|||0000-0003-0599-9215
  • Riera, Antoni|||0000-0001-7142-7675
  • Hnisz, Denes|||0000-0002-6256-1693
  • Salvatella, Xavier|||0000-0002-8371-4185
Transcription factors are among the most attractive therapeutic targets but are considered largely 'undruggable' in part due to the intrinsically disordered nature of their activation domains. Here we show that the aromatic character of the activation domain of the androgen receptor, a therapeutic target for castration-resistant prostate cancer, is key for its activity as transcription factor, allowing it to translocate to the nucleus and partition into transcriptional condensates upon activation by androgens. On the basis of our understanding of the interactions stabilizing such condensates and of the structure that the domain adopts upon condensation, we optimized the structure of a small-molecule inhibitor previously identified by phenotypic screening. The optimized compounds had more affinity for their target, inhibited androgen-receptor-dependent transcriptional programs, and had an antitumorigenic effect in models of castration-resistant prostate cancer in cells and in vivo. These results suggest that it is possible to rationally optimize, and potentially even to design, small molecules that target the activation domains of oncogenic transcription factors.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

hnRNPDL phase separation is regulated by alternative splicing and disease-causing mutations accelerate its aggregation

  • Batlle Carreras, Cristina|||0000-0003-4903-831X
  • Yang, Peiguo
  • Coughlin, Maura
  • Messing, James
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Szulc, Elzbieta
  • Salvatella, Xavier|||0000-0002-8371-4185
  • Kim, Hong Joo
  • Taylor, J. Paul
  • Ventura, Salvador|||0000-0002-9652-6351
Prion-like proteins form multivalent assemblies and phase separate into membraneless organelles. Heterogeneous ribonucleoprotein D-like (hnRNPDL) is a RNA-processing prion-like protein with three alternative splicing (AS) isoforms, which lack none, one, or both of its two disordered domains. It has been suggested that AS might regulate the assembly properties of RNA-processing proteins by controlling the incorporation of multivalent disordered regions in the isoforms. This, in turn, would modulate their activity in the downstream splicing program. Here, we demonstrate that AS controls the phase separation of hnRNPDL, as well as the size and dynamics of its nuclear complexes, its nucleus-cytoplasm shuttling, and amyloidogenicity. Mutation of the highly conserved D378 in the disordered C-terminal prion-like domain of hnRNPDL causes limb-girdle muscular dystrophy 1G. We show that D378H/N disease mutations impact hnRNPDL assembly properties, accelerating aggregation and dramatically reducing the protein solubility in the muscle of Drosophila, suggesting a genetic loss-of-function mechanism for this muscular disorder.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CEBPA phase separation links transcriptional activity and 3D chromatin hubs

  • Christou-Kent, Marie
  • Cuartero, Sergi|||0000-0002-9338-583X
  • Garcia-Cabau, Carla|||0000-0003-0533-0642
  • Ruehle, Julia
  • Naderi, Julian
  • Erber, Julia
  • Neguembor, Maria Victoria
  • Plana-Carmona, Marcos
  • Alcoverro Bertran, Marc
  • de Andrés-Aguayo, Luisa|||0000-0001-6717-242X
  • Klonizakis, Antonios
  • Julià Vilella, Eric
  • Lynch, Cian
  • Serrano, Manuel|||0000-0001-7177-9312
  • Hnisz, Denes|||0000-0002-6256-1693
  • Salvatella, Xavier|||0000-0002-8371-4185
  • Graf, Thomas|||0000-0003-2774-4117
  • Stik, Grégoire|||0000-0002-1404-1992
Cell identity is orchestrated through an interplay between transcription factor (TF) action and genome architecture. The mechanisms used by TFs to shape three-dimensional (3D) genome organization remain incompletely understood. Here we present evidence that the lineage-instructive TF CEBPA drives extensive chromatin compartment switching and promotes the formation of long-range chromatin hubs during induced B cell-to-macrophage transdifferentiation. Mechanistically, we find that the intrinsically disordered region (IDR) of CEBPA undergoes in vitro phase separation (PS) dependent on aromatic residues. Both overexpressing B cells and native CEBPA-expressing cell types such as primary granulocyte-macrophage progenitors, liver cells, and trophectoderm cells reveal nuclear CEBPA foci and long-range 3D chromatin hubs at CEBPA-bound regions. In short, we show that CEBPA can undergo PS through its IDR, which may underlie in vivo foci formation and suggest a potential role of PS in regulating CEBPA function.